On Jan. 22, Secretary Xavier Becera sent a letter to Medicare plans, payers, and state Medicaid and CHIP agencies about upholding their obligations under federal law, coinciding with the 51st anniversary of Roe v. Wade.
Three notes:
- A new set of guidelines to help payers meet existing federal obligations by fully covering a broader range of FDA-approved contraceptives and some devices.
- Updates to the Medicare Part D formulary clinical review process for plan year 2024 to include additional birth control types and intrauterine devices for future plan years.
- Instructing local Medicare administrative contractors to publish educational content on the availability of IUD coverage for certain conditions under Medicare Part B.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 17–19 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
